Warsaw — A European Union-funded project to build a Polish genome map plans to remove gene sequencing technology from China’s BGI Group on data security concerns, said one of the project leaders. The person told Reuters.
The genomic map of Poland’s concerns stems from questions about how Polish genomic data related to national security is used, says a professor at the Institute of Bioorganic Chemistry at the Polish Academy of Sciences, which runs the project. Said Marek Figrelovich.
Figlerowicz was initially concerned report Earlier this year, the National Security Commission on Artificial Intelligence (NSCAI) said the BGI could be acting as a “global collection mechanism for the Chinese government’s genetic database.”
BGI responded by telling Reuters that the US report was “disinformation, not factual.” The Chinese Ministry of Foreign Affairs calls it “unfounded accusations and smears.”
A spokesperson for NSCAI supported the report and recommended that the United States and its allies double down on technologies to better protect patient privacy. Since 2015, Beijing has restricted foreign researchers from accessing Chinese genetic data.
In August, the Human Genetics Commission of the Polish Academy of Sciences said that the “lack of compliance” by what is called a “far eastern company” with the principles of genetic testing ethics raised serious questions. It did not name a company or country, but urged laboratories and scientific institutions to sequence genetics abroad to stop using biotechnology companies there.
Citing estimates that Reuters could not verify, he said that about 100,000 complete Polish genomes could already be in the “Far East” laboratory. According to the Commission, Poland has no control over its sensitive personal data.
Genomic maps, which are expected to cost more than 100 million zloty ($ 25.35 million) and nearly half of the 5,000 Polish genome sequencing program, have been outsourced to a third party since 2019, according to Figlerowicz. ..
The company, Central Europe Genomics Center sp, based in Białystok. He said z oo (CEGC) started using BGI technology last year. Currently, Figrelovich said Poland’s genomic map has decided not to send genetic data abroad and is likely to cancel its contract with CEGC. He added that final decisions not yet approved by funding agencies are expected within next week or two weeks.
As the technology for sequencing genetic data advances and becomes cheaper, the mapping project plans to bring the rest of the sequencing in-house, Figlerowicz said. In this project, we want to ensure that Poland has “independence” of the genome to ensure the security of the data.
CEGC did not respond to a request for comment. Poznan-based biotechnology company Inno-GeneSA, which holds a minority stake in CEGC, said it was unaware of the possibility of cancellation.
The European Union, which provided about 65% of the total funding for the genome map, did not respond to requests for comment. The Polish Ministry of Education and the National Institute of Information Processing were also not involved in funding the project. Polish special services declined to comment.
Reuters report In July, BGI worked with PLA hospitals to develop and improve prenatal screening tests sold in at least 52 countries.
BGI rejected the proposal to work with the military to develop a test under the brand NIFTY, stating that work in a military hospital is not equivalent.
($ 1 = 3.9448 zloty)